Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #67231
advertisement
Tao Y
34
Showing records 1 to 25 |
Display all abstracts from
Tao Y
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Li Q
Molecular Biology Reports
2023; 50: 1321-1331
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Tao Y
Frontiers in cell and developmental biology
2023; 11: 1081898
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Li J
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Jiang J
Ophthalmic Research
2022; 0:
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Zhang Q
Frontiers in cell and developmental biology
2023; 11: 1081898
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Feng P
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Wang D
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Xu J; Tao Y
Ophthalmic Research
2022; 0:
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Meng M
Frontiers in cell and developmental biology
2023; 11: 1081898
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Pottenburgh J
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Lin S
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Pottenburgh J
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Hu C
Ophthalmic Research
2022; 0:
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Bower AJ
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Xu Z
Molecular Biology Reports
2023; 50: 1321-1331
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Huang J
Frontiers in cell and developmental biology
2023; 11: 1081898
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Asanad S
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Zhao J
Molecular Biology Reports
2023; 50: 1321-1331
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Zhang C
Ophthalmic Research
2022; 0:
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Asanad S
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Chen Z
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Lai EW
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Sun X
Ophthalmic Research
2022; 0:
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Luo Z
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Simon C
iScience
2023; 26: 105755
«
1
2
»
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement